AtriCure officer plans sale of 4,519 shares

The prior three-month sales listed for the officer were 3,657 shares for $201,135.00 and 7,763 shares for $407,557.50.

Rhea-AI Filing Summary

AtriCure, Inc. (ATRC) officer Salvatore Privitera gave notice of a proposed sale of 4,519 common shares, with an aggregate market value of $271,140.00. The approximate sale date is September 23, 2026, through Morgan Stanley Smith Barney LLC. The notice also lists Privitera sales during the prior three months: 3,657 common shares for $201,135.00 on September 8, 2026, and 7,763 common shares for $407,557.50 on September 2, 2026.

Key Figures

Proposed sale: 4,519 common shares Aggregate market value: $271,140.00 Shares sold: 3,657 common shares +3 more

6 metrics

Proposed sale 4,519 common shares Approximate sale date September 23, 2026

Aggregate market value $271,140.00 Proposed sale

Shares sold 3,657 common shares September 8, 2026

Aggregate market value $201,135.00 Sale on September 8, 2026

Shares sold 7,763 common shares September 2, 2026

Aggregate market value $407,557.50 Sale on September 2, 2026

Key Terms

Rule 144, Performance Shares

2 terms

Rule 144 regulatory

"sales required by paragraph (e) of Rule 144 to be aggregated"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Performance Shares financial

"Performance Shares"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ATRC shares did Salvatore Privitera propose to sell?

Salvatore Privitera gave notice of a proposed sale of 4,519 common shares, with an aggregate market value of $271,140.00. The approximate sale date is September 23, 2026, through Morgan Stanley Smith Barney LLC.

What ATRC shares did Salvatore Privitera sell during the prior three months?

The notice lists a sale of 3,657 common shares for $201,135.00 on September 8, 2026, and a sale of 7,763 common shares for $407,557.50 on September 2, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/23/2026 - 04:04 PM Accepted by SEC EDGAR 09/23/2026 - 04:03 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001336063
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ATRICURE, INC.
SEC File Number	000-51470
Address of Issuer	7555 Innovation Way Mason OHIO 45040
Phone	(513) 755-4100
Name of Person for Whose Account the Securities are To Be Sold	SALVATORE PRIVITERA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4519	271140.00	50866294	09/23/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2022	Performance Shares	ISSUER			4519	03/01/2022	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
SALVATORE PRIVITERA 7555 Innovation Way Mason OH 45040	Common	09/08/2026	3657	201135.00
SALVATORE PRIVITERA 7555 Innovation Way Mason OH 45040	Common	09/02/2026	7763	407557.50

144: Remarks and Signature

Remarks
Date of Notice	09/23/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Salvatore Privitera
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)